Media

Progesterone receptor–positive (PR+) breast cancer refers to tumors that express receptors for progesterone. These receptors act like molecular switches. When the hormone binds, it can...

Unfortunately glioblastoma, the most aggressive form of brain cancer, is becoming increasingly common.  In the U.S., it accounts for nearly 50% of all malignant brain...

In 2023, researchers from Fox Chase Cancer Center found thyroid hormone triiodothyronine (T3), commonly used to treat hypothyroidism, can induce differentiation in medulloblastoma cells, the...

An important part of cancer treatment is reducing the tumor burden, or the total mass of cancerous tissue in the body. Tumors actively produce byproducts...

Progesterone is present in the body at 100 to 300 times the concentration of estrogen Estrogen often takes center stage, especially in menopause care. Many...

What does PR+ cancer mean? PR+ means the cancer cells produce progesterone receptor proteins, which are designed to bind to progesterone. PR+ status is usually...

As strange as it sounds, some cancer cells can become “addicted” to treatment. Researchers are finding that prolonged exposure to certain treatments can rewire cancer...

Some things to know about progesterone therapy for cancer        A hormone-driven cancer (or hormone-sensitive cancer) is a type of cancer that uses certain hormones to...

Prolactin: The Third Hormone in Breast Cancer Prolactin is a hormone that naturally rises during pregnancy and breastfeeding. It supports the growth of milk-producing glands...

Over the past few years, cancer research has increasingly shifted its focus toward the immune system. New studies on cancer vaccines are making headlines daily,...

A recent study published in Science found that linoleic acid, the main omega-6 fat found in vegetable oils, can directly promote tumor growth in triple-negative...

Women under 50 now face an 82% higher cancer incidence compared to men in the same age group.  According to a recent report from the...